Skip to content

GE HealthCare Technologies GEHC Free cash flow margin

Free cash flow margin at other companies

Danaher logo
DanaherDHR
21.4%+0.8pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
Stryker logo
StrykerSYK
18.1%+2.7pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Agilent Technologies logo
Agilent TechnologiesA
15%-2.9pp
Cardinal Health logo
Cardinal HealthCAH
1.7%+0.6pp

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$27.82B-12.0%
P/E14.6×+0.1×
P/S1.3×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Calculated from GE HealthCare Technologies’s reported figures.

Based on trailing twelve months.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's free cash flow margin?
GE HealthCare Technologies (GEHC) reported free cash flow margin of 7.2% in Q1 2026.
What does free cash flow margin mean?
How much real, spendable cash each sales dollar generates after reinvestment.
How do you interpret free cash flow margin?
A high and rising FCF margin is the hallmark of a cash-generative business. Persistent gaps between net margin and FCF margin warrant a look at working capital or capital intensity.
How does free cash flow margin compare across companies?
Strong cross-company quality signal; capital-light compounders post structurally higher FCF margins than asset-heavy peers.